Eliseo J. Pérez-Stable

Eliseo J. Pérez-Stable is a Cuban-American physician and researcher known for his work in health disparities and minority health. He is the Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH).
Early Life and Education[edit]
Pérez-Stable was born in Cuba and immigrated to the United States with his family. He completed his undergraduate education at the University of Miami, where he earned a Bachelor of Science degree. He then attended the University of California, San Francisco (UCSF) for his medical training, earning his Doctor of Medicine (M.D.) degree.
Career[edit]
After completing his medical degree, Pérez-Stable joined the faculty at UCSF, where he focused on primary care and health disparities research. He became a prominent figure in the field of minority health, particularly in the context of Latino health.
In 2015, Pérez-Stable was appointed as the Director of the NIMHD. In this role, he has been instrumental in advancing research on health disparities and promoting the health of minority populations. His work has emphasized the importance of social determinants of health and the need for culturally competent care.
Research and Contributions[edit]
Pérez-Stable's research has covered a wide range of topics, including tobacco control, cancer prevention, and chronic disease management among minority populations. He has published numerous articles in peer-reviewed journals and has been a vocal advocate for policies aimed at reducing health disparities.
Awards and Honors[edit]
Throughout his career, Pérez-Stable has received several awards and honors for his contributions to medicine and public health. These include recognition from professional organizations and academic institutions for his work in advancing minority health.
Personal Life[edit]
Pérez-Stable is married and has children. He continues to be active in both his professional and personal life, advocating for health equity and mentoring the next generation of healthcare professionals.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian